HemaSphere (May 2023)
P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA (MM) AFTER EXPOSURE TO NON-CELLULAR ANTI-B-CELL MATURATION ANTIGEN (BCMA) IMMUNOTHERAPY
- N. van de Donk,
- M.-V. Mateos,
- Y.C. Cohen,
- P. Rodriguez-Otero,
- B. Paiva,
- A.D. Cohen,
- T. Martin,
- A. Suvannasankha,
- D. Madduri,
- C. Corsale,
- J.M. Schecter,
- K.C. De Braganca,
- C.C. Jackson,
- H. Varsos,
- W. Deraedt,
- T. Roccia,
- P. Mistry,
- X. Xu,
- K. Li,
- E. Zudaire,
- M. Akram,
- L. Pacaud,
- I. Avivi,
- J. San-Miguel
Affiliations
- N. van de Donk
- 1 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands
- M.-V. Mateos
- 2 Hospital Clinico Universitario de Salamanca, Salamanca, Spain
- Y.C. Cohen
- 3 Tel-Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Italy
- P. Rodriguez-Otero
- 4 University of Navarra, Pamplona, Spain
- B. Paiva
- 4 University of Navarra, Pamplona, Spain
- A.D. Cohen
- 5 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- T. Martin
- 6 UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA
- A. Suvannasankha
- 7 Indiana University Simon Cancer Center, Indiana University and Roudebush VAMC, Indianapolis, IN, USA
- D. Madduri
- 8 Mount Sinai Medical Center, New York, NY, USA
- C. Corsale
- 9 Janssen Research & Development, Raritan, NJ, USA
- J.M. Schecter
- 9 Janssen Research & Development, Raritan, NJ, USA
- K.C. De Braganca
- 9 Janssen Research & Development, Raritan, NJ, USA
- C.C. Jackson
- 9 Janssen Research & Development, Raritan, NJ, USA
- H. Varsos
- 9 Janssen Research & Development, Raritan, NJ, USA
- W. Deraedt
- 10 Janssen Research & Development, Beerse, Belgium
- T. Roccia
- 11 Janssen Global Services, Raritan, NJ, USA
- P. Mistry
- 12 Janssen Research & Development, High Wycombe, United Kingdom
- X. Xu
- 9 Janssen Research & Development, Raritan, NJ, USA
- K. Li
- 13 Janssen R&D, Springhouse, PA, USA
- E. Zudaire
- 13 Janssen R&D, Springhouse, PA, USA
- M. Akram
- 14 Legend Biotech USA, Piscataway, NJ, USA
- L. Pacaud
- 14 Legend Biotech USA, Piscataway, NJ, USA
- I. Avivi
- 3 Tel-Aviv Sourasky (Ichilov) Medical Center, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Italy
- J. San-Miguel
- 4 University of Navarra, Pamplona, Spain
- DOI
- https://doi.org/10.1097/01.HS9.0000936240.43628.7e
- Journal volume & issue
-
Vol. 7,
no. S2
pp. 25 – 26
Abstract
No abstracts available.